Tubacex, S.A.
Tubacex, S.A. (0KD1.L) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Tubacex, S.A. (0KD1.L), featuring income statements, balance sheets, and cash flow data.
Tubacex, S.A. (0KD1.L) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Tubacex, S.A. 0KD1.L financial performance.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $369.57M | $213.12M | $186.50M | $417.62M |
| Cost of Revenue | $249.34M | $87.64M | $68.60M | $288.64M |
| Gross Profit | $120.24M | $125.48M | $117.90M | $128.99M |
| Gross Profit Ratio | $0.33 | $0.59 | $0.63 | $0.31 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $543000.00 |
| SG&A Expenses | $89.46M | $40.59M | $41.30M | $99.49M |
| Operating Expenses | $89.46M | $98.04M | $104.40M | $99.49M |
| Total Costs & Expenses | -$338.80M | $185.68M | $173.00M | $388.13M |
| Interest Income | $73000.00 | $0.00 | $8.70M | $9.78M |
| Interest Expense | $17.49M | $18.20M | $0.00 | $0.00 |
| Depreciation & Amortization | $20.86M | $22.61M | $11.08M | $21.19M |
| EBITDA | $59.14M | $51.86M | $24.58M | $60.47M |
| EBITDA Ratio | $0.16 | $0.24 | $0.13 | $0.12 |
| Operating Income | $30.77M | $27.44M | $13.50M | $29.50M |
| Operating Income Ratio | $0.08 | $0.13 | $0.07 | $0.07 |
| Other Income/Expenses (Net) | -$9.98M | -$18.24M | -$8.70M | -$7.86M |
| Income Before Tax | $20.79M | $9.20M | $4.80M | $21.64M |
| Income Before Tax Ratio | $0.06 | $0.04 | $0.03 | $0.05 |
| Income Tax Expense | $3.57M | $1.18M | $0.00 | $2.74M |
| Net Income | $16.39M | $6.46M | $4.80M | $8.53M |
| Net Income Ratio | $0.04 | $0.03 | $0.03 | $0.02 |
| EPS | $0.13 | $0.05 | $0.04 | $0.07 |
| Diluted EPS | $0.13 | $0.05 | $0.04 | $0.07 |
| Weighted Avg Shares Outstanding | $121.69M | $121.61M | $120.79M | $130.19M |
| Weighted Avg Shares Outstanding (Diluted) | $126.22M | $121.61M | $120.79M | $130.19M |
Over the last four quarters, Tubacex, S.A.'s revenue moved from $417.62M in Q4 2023 to $369.57M in Q4 2024. Operating income in Q4 2024 was $30.77M, with a strong operating margin of 8%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Tubacex, S.A. remained robust at $59.14M, reflecting operational efficiency. Net income rose to $16.39M, with an EPS of $0.13. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan